Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- HERC and COVID-19
- Economic Evaluation of Healthcare Technologies
- Measurement and Valuation of Resources
- Measurement and Valuation of Health Outcomes
- Design and Evaluation of Healthcare Systems
- Economics of Population Health
- Ageing
- Clinical Guidelines
- All Completed Studies
- NHS and the UK Healthcare System
- All Current Studies - Clinical Trials (Economic Evaluation)
- Economics of Blood Transfusion
- Economics of Screening
- Genomic Technologies
- Methodological Developments in Economic Evaluation
- Modelling
- Miscellaneous
- Estimating Costs for Economic Evaluation
- DCE Research at HERC
- Willingness to Pay
- Measurement of Capabilities
- Health Inequalities
- Patient Safety
- Radon
- Maternal and Child Health
- Mental Health
- Heart Disease
- Diabetes
- Disease Cost Studies
- Global Health
- Population Datasets
- MAPS: reporting statement for studies mapping onto preference-based outcome measures
- Coeliac Disease
- Introduction to Health Economic Evaluation
- Integrating Economic Evaluation into Clinical Trials
- Applied Methods of Cost-Effectiveness Analysis
- Cost-effectiveness Analysis in Stata Using Participant-level Data
- Inequality in Health and Health Care: Theoretical and Empirical Considerations
- DPhil in Population Health
- RELATED COURSES AT OXFORD UNIVERSITY
- Symposium to mark the 60th Anniversary of the Hinchliffe Report
- HERC in the news - 2016 CMO Annual Report 'Generation Genome'
- Previous News
- How do pay rises affect inequality?
- NEW: DPhil Opportunities
- Chronic kidney disease policy model
- OUT NOW: HERC database of mapping studies version 6.0
- REGISTRATION NOW OPEN: Resource Allocation in Personalised Medicine: Evaluation, Translation & Ethics
- NEW: HERC database of health economics and genomics studies
- NDPH is five
- Campaigns about unnecessary antibiotic use and antibiotic resistance could backfire
- HERC Newsletter - Issue 24 OUT NOW!
- Congratulations to Mara Violato on being awarded the title of University Research Lecturer!
- DPhil Opportunities at HERC
- HERC announcement: Change in leadership
- HERC Newsletter - Issue 25 OUT NOW!
- Short courses in health economics: Introduction to Health Economic Evaluation - Booking now open for 2019
- Health expenditure on patients with multiple conditions
- Applied Methods of Cost-Effectiveness Analysis (3-Day) - Booking now open for July 2019!
- Ten-year outcomes of the Arterial Revascularisation Trial
- Statin therapy reduces cardiovascular disease risk in older people
- Philip Clarke, presents 'The origins of health economic evaluation' at Centre for Health Economics, University of York
- HERC Newsletter - Issue 26 OUT NOW!
- Low calorie meal replacements are a cost-effective routine treatment for obesity in the NHS
- Economics can help tackle the global challenge of antimicrobial resistance
- New update of HERC Database of Mapping Studies
- HERC Newsletter - Issue 27 OUT NOW!
- HERC at iHEA: Basel 2019 Congress
- Achieving Type 2 diabetes treatment targets would improve health and reduce healthcare costs
- HERC research in the spotlight: consider shorter courses when prescribing antibiotics
- Congratulations to Sarah Wordsworth on being appointed Professor of Health Economics and Genomics
- NEW: MSc in Precision Cancer Medicine
- Symposium reveals NHS challenges have changed little since 1959
- HERC Newsletter - Issue 29 - November 2019 OUT NOW!
- CANCELLED: Oxford Workshop: Ageing Without Living Longer
- The acceptability of using a lottery to allocate research funding: a survey of applicants
- The cost of self-harm to hospitals in England
- Exit strategy: how to lift lockdown
- HESG Virtual Plenary: 50th Anniversary of the QALY. Tuesday 19th May 2020
- Work begins on UK system for estimating COVID-19 cases from wastewater
- HERC part of new University programme of AI research to improve lung cancer screening
- Five Senior HERC researchers awarded Associate Professor and University Research Lecturer status!
- HERC Newsletter - Issue 32 - August 2020
- Governments should be thinking now about how they would allocate a safe and effective COVID-19 vaccine
- New Research: Child Anxiety Treatment in the context of COVID-19 (Co-CAT): Enabling Child and Adolescent Mental Health Services (CAMHS) to provide efficient remote treatment for child anxiety problems
- Version 8 of the HERC Database of Mapping Studies: Now Available
- Forthcoming HERC Talk: Professor Charles Manski 'Forming COVID-19 Policy Under Uncertainty'
- DPhil in Population Health: Applications for entry in October 2021 are now open.
- New look HERC Newsletter - Issue 33 - November 2020 AVAILABLE NOW
- New disease forecasting model can identify the most beneficial and best-value treatments for patients with impaired kidney function
- Launch of the NIHR Incubator for Mental Health Research
- HERC Senior Researcher interviewed on R4's "How to Vaccinate the World" - Podcast available
- HERC Newsletter - Issue 35 - May 2021
- Study shows overwhelming public support for donating vaccines to low-income countries
- COVID-19 Infections Survey reveals similar, significant reductions in COVID-19 infections with single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine
- New study demonstrates cost-effectiveness of life-saving treatments for deadly fungal infections in HIV patients
- Cash incentives could help boost COVID-19 vaccine uptake
- A dynamic approach improves accuracy of predicting outcomes for people with type 2 diabetes
- DPhil in Population Health: Applications for entry in October 2022 are now open
- Presentations now available from the September 2021 Oxford BRC Virtual Symposium
- HERC Newsletter - Issue 37 - November 2021, available now
- Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world-first study
- Dr Koen Pouwels awarded for pandemic surveillance work
- Health Economics Research Centre celebrates 25 years
- HERC Newsletter - Issue 38 - 25th Anniversary Special Edition, December 2021, available now
- Study suggests how to make e-cigarettes more appealing to reluctant tobacco quitters
- Health Economics Research Centre (HERC) Virtual Visitor Scheme (Round 2: Latin America)
- Psychosocial assessments for self-harm are highly cost-effective, new analysis shows
- Can a pioneering online programme help parents reduce anxiety in young children?
- Direct questions better than hypothetical situations in predicting attitudes to risky health behaviours
- Study indicates reasons for decline in death rates from heart attacks
- Excess weight in childhood carries significant short- and long-term economic costs
- HERC welcomes first cohort of virtual visitors
- Genetic testing could reduce adverse effects and hospital costs of a widely used chemotherapy
- Online - NIHR Oxford BRC Virtual Symposium on 'Levelling Up: Evidence based approaches to reducing inequalities in health and access to care'
- Study finds COVID-19 vaccines reduce long COVID symptoms from previous infection
- People with severe mental illness were significantly affected by COVID-19 pandemic
- New project aims to inform national action plans to combat antimicrobial resistance
- New study finds that politicians typically enjoy longer lives than general populations
- NIHR Oxford BRC Virtual Symposium on 'Levelling Up: Evidence based approaches to reducing inequalities in health and access to care'
- Recording available of recent talk given by Lachlan Cameron, Health Economics PhD Student, University of Melbourne
- Recording available of recent talk given by Assistant Prof Aaron Winn, Medical College of Wisconsin
- Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease
- HERC Newsletter - Issue 42 - December 2022. Available Now
- Oxford Population Health to lead a new programme of research on demand for health and social care
- New approach to nail bed injury surgery could significantly cut NHS costs
- Measuring health-related quality of life during pandemics
- HERC Visiting Health Economic Scholars Program launches
- New book on "Economic Evaluation in Genomic and Precision Medicine" published
- How has COVID-19 impacted AMR?
- Video abstract on the recent iCATS-i2i paper on the multifaceted consequences and costs of child anxiety problems.
- A systematic review of 151 studies found that most intervention(s) targeting childhood excess weight or seeking to improve diet or physical activity were deemed cost-effective compared with usual care.
- Cardiovascular disease cost the European Union economy €282bn in 2021
- New publication on cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young
- New publication on Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of 3 European countries
- How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review
- Trends in all-cause mortality among adults with diagnosed type 2 diabetes in West Malaysia: 2010 - 2019
- The affordability and obtainability of gluten-free foods for adults with coeliac disease following their withdrawal on prescription in England: A qualitative study
- Child mental health and income gradient from early childhood to adolescence: Evidence from the UK
- Small cash incentives improve vaccine uptake in rural areas of African countries
- Small cash incentives improve vaccine uptake in rural areas of African countries
- Measuring health-related quality of life during pandemics
- Budgeting healthcare services for care home residents: why mental health matters
- New NIHR Research Support Service hub to support health, public health and social care researchers
- Oxford Population Health to lead a new programme of research on demand for health and social care
- Excess weight in childhood has significant short- and long-term economic costs
- Direct questions better than hypothetical situations in predicting attitudes to risky health behaviours
- Budgeting healthcare services for care home residents: why mental health matters
- How do pay rises affect inequality?
- New study into methods of diagnosing fatty liver disease
- The effects of vascular and nonvascular adverse events and of niacin-laropiprant on health and healthcare costs
- NHS needs to perform more weight loss surgery to curb the obesity epidemic, argue experts
- When should blood transfusions be given after cardiac surgery?
- UK dementia and stroke research remains underfunded
- New version of HERC Database of Mapping Studies now available!
- How can subscription-based economic model help unblock pipeline for new antibiotics.
- New publication on Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia
- A randomised trial in rural Ghana has confirmed that tailored cash incentives bolster the take-up of Covid vaccines
- Prevalence and short-term change in symptoms of anxiety and depression following bariatric surgery: a prospective cohort study
- HERC researcher Associate Professor Mara Violato was quoted in The Times Health Commission Report
- The direct and spillover effects of diabetes diagnosis on lifestyle behaviours
- Helping parents to help their children: a digital intervention for child anxiety problems
- Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?
- Duration of protective immunity following COVID-19 vaccination of individuals with underlying health conditions: A rapid review
- Assessing the relationship between coverage of essential health services and poverty levels in low- and middle-income countries
- Does workforce explain the relationship between funding and patient experience? A mediation analysis of primary care data in England
- Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
- Recruitment opportunity at HERC: Grade 8 Teaching & Research Fellow (Health Economics)
- Excess weight had major impact on hospital resource use during the COVID-19 pandemic
- Robot radiotherapy could improve treatments for eye disease
- Proposals by Prof Clarke for an RCT of different types of dental insurance has been highlighted in a speech by Dr Andew Leigh, Minister for Competition at a conference on the 40th Anniversary of Australia’s Medicare
- Urgent action is required to stem the increasing costs of major conditions
- The impact of winning funding on researcher productivity results from a randomized trial
- Preventive vaccination could be a key strategy against Lassa fever and the next pandemic
- Statins are a cost-effective way of reducing the risks of heart disease and stroke in older adults
- HERC colleagues excel at Oxford Half Marathon
- RSV vaccination could be vital in the battle against antimicrobial resistance
- Oxford Population Health researchers win AMR Surveillance Data Challenge Grand Prize
- Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies
- Associate Professor Mara Violato is a contributor to the UK Parliament POSTnote (research-based policy briefing)
- Empagliflozin is a cost-effective treatment for people with chronic kidney disease
- Barbara Kitchener
- David Jones
- Alastair Gray
- Borislava Mihaylova
- Helen Dakin
- Laurence Roope
- Liz Stokes
- Sarah Wordsworth
- Jane Wolstenholme
- Filipa Landeiro
- Judit Simon
- Yaling Yang
- Oliver Rivero-Arias
- Adrian Towse
- Mara Violato
- Philip Clarke
- Liz Morrell
- John Buckell
- Rositsa Koleva-Kolarova
- Claire Williams
- James Altunkaya
- Junwen Zhou
- Wadzanayi Muchenje
- Zachary Abel
- Keyu Li
- Sarah Njenga
- Sally Sansom
- Shuye Yu
- Chloe Gee
- Xuemin Zhu
- Sophie Cole
- Natasha Salant
- Rhys Thomas
- Jack Pollard
- Fred McElwee
- Harry Street
- Maria Cardenas
- Rebecca Njuguna
- Sasha Shepperd
- Xiaowen Du
- Luke Paterson
- Miriam Lúcar Flores
- Madison Luick
- Xiaowen Du
- James Lathe
- Miguel Niño-Zarazúa
- Henry Cutler
- Pharmaceutical policies in the long run: Reflections on 60th anniversary of the Hinchliffe Report
- Estimating pooled survival benefit using individual patient-level data meta-analyses in cost-effectiveness analysis of health care technologies: case and simulation study.
- Bayesian methods (model averaging and belief networks) when mapping from the Modified Rankin Scale to the EQ-5D
- Which health technologies, at what price and for whom: estimating the cost-effectiveness threshold for NICE and the NHS
- Management of low-grade dysplasia in ulcerative colitis in the UK National Health Service: the cost-effectiveness of immediate surgery versus ongoing surveillance.
- Impact of performance-based financing in a low resource setting: a decade of experience in Cambodia
- Modelling the cost of cancer: a system of equations approach to understanding inter-relationships
- Measuring uncertainty preferences for health
- Using CART to identify thresholds and hierarchies in funding decisions.
- Terrorism and Human Capital at Birth: Bomb Casualties and Birth Outcomes in Spain
- Understanding the underutilisation of evidence from economic evaluations in healthcare: a mixed methods design
- Cost-effectiveness - Lessons from the Global Response to HIV/AIDS
- Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
- Banning alcohol sales at night and hospital admissions in Germany
- Predicting cancer patients’ quality of life: an analysis of the relationship between utility, treatment regimes and time
- Opportunity costs of healthcare beds: How to estimate them properly?
- If you don't snooze you lose. Evidence on health and weight.
- A Brief History of Economic Evaluation.
- The determinants of GP referrals and elective hospital admissions: a practice level study.
- Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures
- Cost-effectiveness modelling of the liver disease pathway.
- Prospects for the use of Mendelian Randomization in Economic Evaluation
- Dealing with missing quality of life data in clinical trials .
- Using discrete choice experiments to understand benefit-risk trade-offs
- What is the impact on alcohol purchases of increasing the price of sugary drinks?
- Incentives, Choice and Public Health Policy
- Macroeconomic Conditions and Opioid Abuse
- Missing data in randomised trials: beyond missing at random
- Are Public Hospitals Overcrowded? Evidence from Trauma and Orthopaedics in England
- Use of Rapid Reviews in Health Technology Assessment Processes – Effective or Impractical? A Review of the Irish System & Lessons for Others.
- Developing New Policies in Response to Rising Drug Prices in the U.S.
- Introducing rational healthcare prioritisation in Ghana: Methods and Challenges
- Value of Sample Information as a Tool for Clinical Trial Design
- EQ-5D-3L vs EQ-5D-5L: what are the consequences for cost-effectiveness in the UK?
- Carer and family effects in economic evaluation: an overview of recent research
- Using electronic health records in health economic modelling studies.
- Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis
- Discrete Choice Experiments to Inform Programming and C-E Modelling of HIV Prevention
- Tracking Progress towards Universal Health Coverage in Kenya
- How do FDA policies impact demand for cigarettes and e-cigarettes in the US tobacco market? Predictions from discrete choice experiments
- Estimating survival: Does patient reported quality of life matter?
- Do consumers respond to “sin taxes” heterogeneously? New evidence from the tax on sugary drinks using retailer scanner data
- Multi-Criteria Decision Analysis for Comparative Value Assessment throughout the Drug Lifecycle
- Implications of non-marginal budgetary impacts in health technology assessment.
- Health Preference Research: past, present and possible future
- A Direct Regression Approach to Decomposing Socioeconomic Inequality of Health
- Oxford Health Economics Workshop 2019
- The causal effect of adiposity on hospital costs: Mendelian Randomization analysis of over 300,000 individuals from the UK Biobank
- Dynamic Consistency, Sample Selection and Attrition: A Panel Experiment on Individual Discount Rates
- Quality of Life Trajectories in Total Knee Replacement Patients: What can they tell us?
- Using whole disease modelling to evaluate all key interventions for schizophrenia
- Social Norms and Free-Riding in Influenza Vaccine Decisions: An Online Experiment
- Strategies to reduce inappropriate antibiotic use
- Forthcoming Talks (by HERC Researchers)
- Sex, risk, and preferences: Using stated preference data to model behaviour in HIV prevention.
- A personalized screening strategy for diabetic retinopathy: a cost-effectiveness perspective
- Difference-in-differences estimation when the dependent variable is ordinal.
- HESG Virtual Plenary: 50th Anniversary of the QALY
- Oxford Workshop: Ageing without living longer [CANCELLED]
- Dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease
- Rise or fall in equality? The dynamics of inequality measures
- Oxford Economics of Health Seminar Series 2020
- OXFORD HEALTH ECONOMICS SEMINAR: Skill Formation and the Trouble with Child Non-Cognitive Skill Measures
- OXFORD HEALTH ECONOMICS SEMINAR: Class Influence on Drug Consumption Among Teenagers
- Advances in decision modeling using R. Collaborating in an open source space
- TALK CANCELLED
- OXFORD HEALTH ECONOMICS SEMINAR: [CANCELLED]
- Learning healthcare systems for cost-effective precision oncology.
- Smokers’ choices and addiction: a hybrid choice model approach in the US
- FORMING COVID-19 POLICY UNDER UNCERTAINTY
- The regional effect of Australia’s Consumer Directed Care model for older people
- The impact of locating primary care physicians in emergency departments
- Socioeconomic inequality in access to and quality of emergency care
- Distributional cost-effectiveness analysis and the preferences of the UK-public: Two choice-experiments
- Methods for population-adjusted indirect comparisons based on individual and aggregate level data
- FORTCOMING EVENT: Virtual ISPOR 2021, 17-20 May 2021
- Is subjective unmet need for mental health care a valid measure compared to a more 'objective' metric?
- Improving our use of existing antimicrobial resistance data and generating better data on optimal antibiotic duration by improving trial design in veterinary and human medicine
- Extrapolation in Economic Evaluation – What we do right and what we do wrong!
- Vaccine Hesitancy – evidence from a discrete choice experiment
- Patient-centred value assessment
- Analysis of the career progression of early career researchers in the UK
- Eliciting health preferences in small and heterogeneous groups: an introduction to preference paths and their kaizen tasks with three examples
- Online Talk: Measuring Health Utilities for COVID-19 Illness: Implications for Valuing Child Health
- Online Talk: The OPUF tool: a new approach for eliciting health state preferences on the societal, group, and individual level.
- Online Talk: Using routine healthcare data to inform cost-effectiveness analysis of complex pathways: case study of cost-effectiveness analysis of cascade testing protocols for familial hypercholesterolaemia.
- Child Mental Health and Income Gradient from Early Childhood to Adolescence: Evidence from the UK
- COVID-19 Infection Survey and the use of multilevel post-stratification
- Reference modelling using a national registry - the Epidemiological Modelling of Australian Patients with Myeloma (EpiMAP Myeloma) project
- Understanding the role of mental health in online gambling decisions: A Discrete Choice Experiment
- Online - NIHR Oxford BRC Virtual Symposium on 'Levelling Up: Evidence based approaches to reducing inequalities in health and access to care'
- Development and Validation of the Diabetes Outcome Model for the US (DOMUS)
- Applying trial-derived treatment effects to real-world populations: how to estimate cost-effectiveness when modelling complex hazards
- The role of economic research in informing investments into maternal, child and youth mental health
- Wellbeing-adjusted life years (WELBYs) in policy and practice
- Redesigning pricing and reimbursement models for high-cost drugs in South Korea
- The Australian paediatric multi-instrument comparison (P-MIC) study
- Outsourcing health-care services to the private sector and treatable mortality rates in England, 2013–20: an observational study of NHS privatisation
- What is the future for integrated care in the National Health Service?
- Understanding the impact of lockdowns on short-term excess mortality in Australia
- What is “The Price of Life”? Communicating cost-effectiveness to the public
- Health Economics & Policy Seminar Series
- HESG Summer 2023 Meeting: Keble College, University of Oxford
- Which way up? Consistency, anti-consistency and inconsistency of social welfare and inequality partial orderings for ordinal data
- Disease expenditure estimates for all OECD countries, and impacts on health expenditure by OECD country from achieving SDG goal 3.4 (33% reduction in NCD mortality)
- Modelling health-based choice behaviour using R: illustrating the Apollo package with smoking choices
- Measuring NHS Productivity during a health crisis
- Inequality measurement for bounded variables
- Improving medical decision making: Evidence and uncertainty considerations
- The use of real-world data for estimating relative treatment effects in National Institute for Health and Care Excellence (NICE) health technology appraisals: a systematic review
- We need to talk about values: articulating normative reasoning in health technology assessment
- An Examination of “Excluded” Health Services in Canada: A Focus on Mental Health Services for Children
- Saving lives, saving money? The effects of a large community-wide, multisectoral suicide prevention program on healthcare use and costs
- Meta-analysis of utility values, including using the Bayesian Power Prior
- COVID-19-related catastrophic health expenditure and multidimensional poverty in Ghana: further discussions 20 years after implementing a social health insurance policy
- The History of Health Economics
- Methods from data-science to improve the transparency and usability of health economic models
- Recordings from the Health Economic and Policy Seminar Series
- Megatrends in Global Health and evolution of the Australian Health System
- Policymaking during the COVID-19 pandemic: reflections from a Year at the Council of Economic Advisers
- Commemorative event for Professor Ray Fitzpatrick Friday 6 September 2024 Trinity College, Oxford
- Health Economics and Genomics Seminar
- Data-Driven Decisions: The Case for Randomised Policy Trials
- The Cost of Health Care for Children with Severe anaemia in Malawi, Kenya and Uganda
- Managing Health Policy in a Crisis: Lessons in Leadership: Covid Case Study
- Going beyond Randomised Controlled Trials to assess treatment effect heterogeneity across target populations
- The decline in health inequalities by wealth since 1860 in the UK: Data from 66,000,000 people
- Discrete choice experiments and choice models in health
- Exploring the preferences of younger women for a breast cancer risk prediction service
- Bridging Health and Economics: Showcasing Research across the NIHR Oxford BRCs and ARC
- Active Ageing and COVID-19: Change in Behaviour
- Financial Consequences of Undiagnosed Memory Disorders & Algorithms for Early Detection
- HERC database of mapping studies
-
Supporting Material for HERC Publications
- Mixed treatment comparison of repeated measurements of a continuous endpoint
- The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
- Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score
- OPTIONS
- Review of statistical methods for analysing healthcare, resources and costs - additional material
- WHO Handbook on Indoor Radon: a public health perspective
- Mapping Modified Rankin Scale responses to EQ-5D utility values
- Supporting Material for Treatment Pathways, Resource Use, and Costs of Endovascular Coiling Versus Surgical Clipping After aSAH
- Supporting materials to the BMJ paper on the economic evaluation of the DiGEM study
- SF-12 Responses and EQ-5D Utility Values
- Supporting material for UKPDS Study No.65
- Variance-covariance matrices for ACHE mapping algorithms
- The Interactive Compendium of Health Datasets for Economists
- Decision Modelling for Health Economic Evaluation
- Handbooks in Health Economic Evaluation
- Economic Evaluation in Clinical Trials
- Applied Methods of Cost-effectiveness Analysis in Healthcare
- Applied Methods of Cost-Benefit Analysis in Health Care
- The influence of cost-effectiveness and other factors on NICE decisions
- HERC database of health economics and genomics studies